PROGRAM
Toward Elimination of Viral Hepatitis:
Achievements, Challenges, and Prospects
September 21-23, 2023 ㅣ BEXCO, Busan, Korea
DAILY PROGRAM
08:30-09:30
Symposium 3-1. Occult Hepatitis Virus Infection and Post-Cure Virologic Failure
Patrick Kennedy (Queen Mary Univ. of London, UK), Kwan Sik Lee (CHA Univ., Korea)
- 08:30-08:45
-
A Twist to a Cure of HCV Infection: Occult HCV Infection
Atsumasa Komori (Nagasaki Univ., Japan)
- 08:45-09:00
-
Re-Infection of HCV Post-SVR
Ki Tae Yoon (Pusan National Univ., Korea)
- 09:00-09:15
-
Occult HBV Infection: The Fate and Clinical Implications
Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong)
- 09:15-09:30
-
Threat: HBV Reactivation after Resolved Hepatitis B
Su Jong Yu (Seoul National Univ., Korea)
09:30-10:30
Keynote Lecture 3. What Happens to the Liver after a Cure of Viral Hepatitis?
Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong), Marc G. Ghany (NIH, USA)
- 09:30-09:50
-
cccDNA and HBV Functional Cure Is CccDNA the Chicken or the Egg?
Robert G. Gish (Hepatitis B Foundation, USA)
- 09:50-10:10
-
HBV Integration as a Novel Biomarker and Barrier to a Cure for HBV Infection
Patrick Kennedy (Queen Mary Univ. of London, UK)
- 10:10-10:30
-
Immune Reconstitution after HCV Clearance with Direct Antiviral Agents
Tatsuya Kanto (National Center for Global Health and Medicine, Japan)
- 10:30-10:50
Coffee Break
10:50-11:20
State-of-the-Art Lecture 3.
Shiv Kumar Sarin (Institute of Liver & Biliary Sciences, India)
- 10:50-11:20
-
A Roadmap to Eliminating Viral Hepatitis
Norah Terrault (Univ. of Southern California, USA)
11:20-11:50
Debrief Session
Jeong Won Jang (The Catholic Univ. of Korea, Korea)
- 11:20-11:30
Viral Hepatitis Debrief
Hye Won Lee (Yonsei Univ., Korea)
- 11:30-11:40
Non-Viral Liver Disease Debrief
Pil Soo Sung (The Catholic Univ. of Korea, Korea)
- 11:40-11:50
Wrap-Up
Jeong Won Jang (The Catholic Univ. of Korea, Korea)
- 11:50-12:20
Closing & Award Ceremony
08:30-09:30
Symposium 3-2. Precision Medicine for the Cure of Viral Liver Disease
W. Ray Kim (Stanford Univ., USA), Joon Hyoek Lee (Sungkyunkwan Univ., Korea)
- 08:30-08:45
-
Personalized Management of Viral Hepatitis of the Present and the Future
Maria Buti Ferret (Hospital Universitario Valle Hebron, Spain)
- 08:45-09:00
-
Risk Stratification for HCC in Chronic Hepatitis B: A Promise for Precision Medicine
Won Sohn (Sungkyunkwan Univ., Korea)
- 09:00-09:15
-
Host and Genetic Factors for Precision Medicine towards a Cure of Viral Hepatitis
Kazuaki Chayama (Hiroshima Univ., Japan)
- 09:15-09:30
-
Biomarker Discovery and Application for Liver Disease in the Era of Precision Medicine
Sun Young Yim (Korea Univ., Korea)
07:30-08:20
Early Morning Workshop 3. Fibrosis Regression after Antiviral Therapy in Patients with Chronic Viral Hepatitis
Atsumasa Komori (Nagasaki Univ., Japan)
- 07:30-07:42
-
Fibrosis Regression after HCV Treatment and Its Clinical Significance
Jeong-Ju Yoo (Soonchunhyang Univ., Korea)
- 07:42-07:54
-
Clinical Implication of On-Therapy Fibrosis Regression in Chronic Hepatitis B
Mi Na Kim (Yonsei Univ., Korea)
- 07:54-08:20
-
Discussion
Discussant: Jeong-Ju Yoo (Soonchunhyang Univ., Korea), Mi Na Kim (Yonsei Univ., Korea), Sung Jae Park (Inje Univ., Korea), Roongruedee Chaiteerakij (Chulalongkorn Univ., Thailand)
07:30-08:20
Early Morning Workshop 4. Screening and Prognosis of HDV Infection with Case Discussion
Jose D. Sollano (The Univ. of Santo Tomas, Philippines)
- 07:30-07:37
-
Threat: Who Should Be Screened for HDV Infection? - Case Presentation
Hee Yeon Kim (The Catholic Univ. of Korea, Korea)
- 07:37-07:45
-
Who Should Be Screened for HDV Infection?
Jae Hyun Yoon (Chonnam National Univ., Korea)
- 07:45-07:57
-
Prognosis of HDV: Risk Factors and Whom to Treat
Lubna Kamani (Liaquat National Hospital, Pakistan)
- 07:57-08:20
-
Discussion
Discussants: Hee Yeon Kim (The Catholic Univ. of Korea, Korea), Jae Hyun Yoon (Chonnam National Univ, Korea), Lubna Kamani (Liaquat National Hospital, Pakistan), Ji Hoon Kim (Korea Univ., Korea)
